98642-44-5

Basic information

• Product Name: tert-butyl 3-hydroxypropylmethylcarbamate
• Synonyms: tert-butyl 3-hydroxypropylmethylcarbamate;(3-N-BOC-METHYLAMINO)-1-PROPANOL;N-Methyl-N-boc-aminopropan-3-ol;(3-Hydroxy-propyl)-Methyl-carbaMic acid tert-butyl ester;N-(3-Hydroxypropyl)-N-Methyl-;N-Boc-3-(MethylaMino)-1-propanol;tert-Butyl (3-hydroxypropyl)
• CAS NO: 98642-44-5
• Molecular Formula: C₉H₁₉NO₃
• Molecular Weight: 189.25
• Product Categories: Aliphatics;Amines;Miscellaneous Reagents
• Mol File: 98642-44-5.mol
• Article Data: 36

Chemical Properties

• Melting Point: NA
• Boiling Point: 120 °C(Press: 0.08 Torr)
• Appearance: /
• Density: 1.020±0.06 g/cm3(Predicted)
• Storage Temp.: Refrigerator
• Solubility: Chloroform, Dichloromethane, DMSO, Ethyl Acetate
• PKA: 14.99±0.10(Predicted)
• CAS DataBase Reference: tert-butyl 3-hydroxypropylmethylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-hydroxypropylmethylcarbamate(98642-44-5)
• EPA Substance Registry System: tert-butyl 3-hydroxypropylmethylcarbamate(98642-44-5)

Safety Data

• Hazardous Substances Data: 98642-44-5(Hazardous Substances Data)

Usage

Chemical Properties

Light Yellow Oil

Uses

N-Methyl-N-boc-aminopropan-3-ol (cas# 98642-44-5) is a compound useful in organic synthesis.

Upstream product

• 114326-13-5 N-methyl-N-(tert-butoxycarbonyl)propanolamine tert-butyldimethylsilyl ether 
• 169268-90-0 3-N-tert-butoxycarbonylamino-N-methyl-1-propene 
• 119740-95-3 methyl 3-(N-tert-butoxycarbonyl-N-methyl)-aminopropionate 
• 42116-55-2 methyl 3-tert-butoxycarbonylaminopropionate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 58885-58-8 N-tert-butoxycarbonyl-3-aminopropanol 
• 114326-12-4 [3-(tert-butyldimethylsilanyloxy)propyl]carbamic acid tert-butyl ester 
• 42055-15-2 N-methyl-3-hydroxypropylamine 
• 156-87-6 propan-1-ol-3-amine 

Downstream Products

• 114326-14-6 N-(tert-butoxycarbonyl)-N-methyl-3-chloropropylamine 
• 42055-15-2 N-methyl-3-hydroxypropylamine 
• 156-87-6 propan-1-ol-3-amine 
• 905991-57-3 methyl (4-{3-[(tert-butoxycarbonyl)(methyl)amino]propoxy}-3-chlorophenyl)acetate 
• 868990-46-9 3-benzyloxycarbonylamino-5-(tert-butoxycarbonyl-methyl-amino)-pentanoic acid tert-butyl ester 
• 868990-44-7 3-[benzyl-(1-phenyl-ethyl)-amino]-5-(tert-butoxycarbonyl-methyl-amino)-pentanoic acid tert-butyl ester 
• 114325-83-6 Methyl-[3-(2-oxo-2-phenyl-ethylsulfanyl)-propyl]-carbamic acid tert-butyl ester 
• 1039032-89-7 C₂₀H₂₆N₄O₄S 
• 1033225-20-5 tert-butyl (3-(6-fluoro-2,2-dioxido-3-phenyl-2,1,3-benzothiadiazol-1(3H)-yl)propyl)methylcarbamate 
• 1246248-48-5 1-(2-{[6-({4-[{3-[(tert-Butoxycarbonyl)(methyl)amino]propyl}(isopropyl)carbamoyl] phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate 
• 1246247-20-0 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(cyclopropyl)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate 
• 1246248-51-0 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate 
• 1613513-31-7 3,5-dichlorobenzyl 4-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperazine-1-carboxylate 

Relevant articles and documents

RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF

The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have grea

PRODRUG OF NITROXOLINE AND USE THEREOF

The present invention relates to the prodrug of nitroxoline and use thereof. Specifically, the present invention relates to a compound of formula (I) or the pharmaceutically acceptable salt thereof, a preparation method thereof, a pharmaceutical composition comprising the same, as well as a use thereof in anti-infective and anti-tumor drugs. The compound of formula (I) has better pharmacokinetic parameters such as water solubility, blood concentration or half-life relative to nitroxoline. The compound of formula (I) can reduce the number of administrations, and has the possibility of being applied in other fields than the urinary tract field. The definition of each group in formula (I) is as defined in the description.

HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS

The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.